herpes zoster

Showing 1 - 25 of 113

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Vaccine-Preventable Diseases, Herpes Zoster Trial in Seoul, Seongnam-si (CVI-VZV-001, Shingrix)

Recruiting
  • Vaccine-Preventable Diseases
  • Herpes Zoster
  • CVI-VZV-001
  • Shingrix
  • Seoul, Eunpyeong-gu, Korea, Republic of
  • +1 more
Nov 20, 2023

Vaccine-Preventable Diseases, Herpes Zoster Trial in Zhenjiang (Recombinant Herpes Zoster Vaccine, Recombinant Herpes Zoster

Recruiting
  • Vaccine-Preventable Diseases
  • Herpes Zoster
  • Recombinant Herpes Zoster Vaccine
  • Recombinant Herpes Zoster Vaccine Placebo
  • Zhenjiang, Jiangsu, China
    Jiangsu Province Center for Disease Control and Prevention (Chin
Oct 12, 2023

Herpes Zoster Trial in Halifax (Recombinant Zoster Vaccine (Adenovirus Vector) (ChAdOx1-VZV), Zoster Vaccine Recombinant,

Not yet recruiting
  • Herpes Zoster
  • Recombinant Zoster Vaccine (Adenovirus Vector) (ChAdOx1-VZV)
  • +5 more
  • Halifax, Canada
    Canadian Center for Vaccinology
Aug 6, 2023

Herpes Zoster Hospitalizations in Italy

Not yet recruiting
  • Herpes Zoster
  • Comorbidities and Coexisting Conditions
  • Hospitalization
  • L'Aquila, Italy
    University of L'Aquila
Jul 11, 2023

Herpes Zoster Trial in Xinxiang (Low dose Recombinant Herpes Zoster Vaccine (CHO cells), High dose Recombinant Herpes Zoster

Not yet recruiting
  • Herpes Zoster
  • Low dose Recombinant Herpes Zoster Vaccine (CHO cells)
  • +3 more
  • Xinxiang, Henan, China
    Yanjin Center for Disease Control and Prevention
May 4, 2023

Herpes Zoster Subunit Vaccine During Pregnancy in Adult

Not yet recruiting
  • Herpes Zoster
  • Data collection
  • (no location specified)
Mar 31, 2023

Herpes Zoster Trial (Recombinant Human Interferon a-2b Gel (After the Alteration), Recombinant Human Interferon a-2b Gel (Before

Not yet recruiting
  • Herpes Zoster
  • Recombinant Human Interferon α-2b Gel (After the Alteration)
  • Recombinant Human Interferon α-2b Gel (Before the Alteration)
  • (no location specified)
Apr 7, 2023

Herpes Zoster Trial in Makati City (REC610, Shingrix)

Recruiting
  • Herpes Zoster
  • REC610
  • Shingrix
  • Makati City, Metro Manila, Philippines
    Pharma Peak Research Philippines,Inc.
Mar 13, 2023

Herpes Zoster, Vaccine-Preventable Diseases Trial (Low Dose Recombinant Herpes Zoster Vaccine (LZ901), High Dose Recombinant

Not yet recruiting
  • Herpes Zoster
  • Vaccine-Preventable Diseases
  • Low Dose Recombinant Herpes Zoster Vaccine (LZ901)
  • +2 more
  • (no location specified)
Feb 28, 2023

Herpes Zoster Trial (Recombinant Zoster Vaccine, Placebo, Zoster Vaccine Recombinant, Adjuvanted)

Not yet recruiting
  • Herpes Zoster
  • Recombinant Zoster Vaccine
  • +2 more
  • (no location specified)
Feb 6, 2023

Herpes Zoster Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Shingrix)

Not yet recruiting
  • Herpes Zoster
  • Shingrix
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Herpes Zoster Trial in Xinxiang (Low Dose Recombinant Herpes Zoster Vaccine (CHO cells), High Dose Recombinant Herpes Zoster

Active, not recruiting
  • Herpes Zoster
  • Low Dose Recombinant Herpes Zoster Vaccine (CHO cells)
  • +5 more
  • Xinxiang, Henan, China
    Yanjin District Center for Disease Control and Prevention
Feb 1, 2023

Herpes Zoster Trial in Puerto Rico, United States (mRNA-1468, Placebo, Shingrix)

Not yet recruiting
  • Herpes Zoster
  • mRNA-1468
  • +2 more
  • Los Angeles, California
  • +19 more
Jan 18, 2023

Herpes Zoster Trial in Huaian, Lianyungang, Shanghai (RZV, Placebo)

Active, not recruiting
  • Herpes Zoster
  • RZV
  • Placebo
  • Huaian, Jiangsu, China
  • +5 more
Jan 20, 2023

Herpes Zoster Trial in Tartu (HZ/su vaccine)

Recruiting
  • Herpes Zoster
  • HZ/su vaccine
  • Elkridge, Maryland
  • +47 more
Jan 6, 2023

Herpes Zoster Trial in India (HZ/su, Placebo)

Active, not recruiting
  • Herpes Zoster
  • HZ/su
  • Placebo
  • Visakhapatnam, Andhra Pradesh, India
  • +8 more
Jan 6, 2023

Associated Burden of Related Conditions in Alopecia Areata

Completed
  • Alopecia Areata
  • +35 more
  • Exposure of interest (studies 2 & 3).
  • London, United Kingdom
    Momentum Data Ltd
Dec 13, 2022

Herpes Zoster Trial in Bengbu (PEGIFNa1b, Placebo)

Completed
  • Herpes Zoster
  • Bengbu, Anhui, China
    The first affiliated hospital of bengbu medical college
Nov 28, 2022

Herpes Zoster Trial in Worldwide (Herpes Zoster subunit (HZ/su) vaccine (GSK1437173A), Placebo)

Active, not recruiting
  • Herpes Zoster
  • Herpes Zoster subunit (HZ/su) vaccine (GSK1437173A)
  • Placebo
  • Tallinn, Estonia
  • +43 more
Nov 14, 2022

Herpes Zoster Trial (Peginterferon a1b, Peginterferon a1b with valacyclovir, Valacyclovir)

Not yet recruiting
  • Herpes Zoster
  • Peginterferon α1b
  • +2 more
  • (no location specified)
Aug 5, 2022

Cervical Intervertebral Disc Disease, Cervical Spinal Stenosis, Cervical Radicular Pain Trial in Seoul (Fluoroscopic-guided

Active, not recruiting
  • Cervical Intervertebral Disc Disease
  • +4 more
  • Fluoroscopic-guided cervical epidural access
  • Seoul, Korea, Republic of
    Asan medical center
Jul 21, 2022

Herpes Zoster Trial in Hangzhou (Intradermal acupuncture, Sham intradermal acupuncture)

Recruiting
  • Herpes Zoster
  • Intradermal acupuncture
  • Sham intradermal acupuncture
  • Hangzhou, Zhejiang, China
  • +1 more
Jul 14, 2022

Influenza, Herpes Zoster Trial in Nijmegen (Herpes zoster vaccination (Shingrix, GSK), Influenza Vaccine (Fluarix Tetra Northern

Active, not recruiting
  • Influenza
  • Herpes Zoster
  • Herpes zoster vaccination (Shingrix, GSK)
  • +2 more
  • Nijmegen, Gelderland, Netherlands
    Radboud University
May 19, 2022

Herpes Zoster Trial in Tomball (HZ/su, Flu D-QIV, mRNA-1273)

Active, not recruiting
  • Herpes Zoster
  • HZ/su
  • +2 more
  • Tomball, Texas
    GSK Investigational Site
Apr 8, 2022

Herpes Zoster, Shingles Trial in San Antonio (CRV-101 Vaccine Antigen High Dose, CRV-101 Vaccine Antigen Low Dose, Shingrix)

Recruiting
  • Herpes Zoster
  • Shingles
  • CRV-101 Vaccine Antigen High Dose
  • +2 more
  • San Antonio, Texas
    Clinical Trials of Texas
Mar 22, 2022